BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18981857)

  • 1. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Ehtesham M; Stevenson CB; Thompson RC
    Neurosurgery; 2008 Oct; 63(4):E820; author reply E820. PubMed ID: 18981857
    [No Abstract]   [Full Text] [Related]  

  • 2. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
    Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas.
    Liu C; Tian G; Tu Y; Fu J; Lan C; Wu N
    Jpn J Clin Oncol; 2009 Oct; 39(10):625-31. PubMed ID: 19797419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
    Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CXCR4 combined with P504S or P63 in differential diagnosis of benign and malignant prostatic diseases].
    Qu F; Xing YF; Xiao YJ; Xiao CG; Guo HQ
    Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1059-62. PubMed ID: 19157222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of activation of human glioma cell CXCR4 receptor on the expression of vascular endothelial growth factor].
    Yang SX; Bian XW; Jiang XF; Chen JH; Wang QL; Wang JM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):845-7. PubMed ID: 15949405
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
    Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma vascularity correlates with reduced patient survival and increased malignancy.
    Russell SM; Elliott R; Forshaw D; Golfinos JG; Nelson PK; Kelly PJ
    Surg Neurol; 2009 Sep; 72(3):242-6; discussion 246-7. PubMed ID: 19329156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
    Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
    J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
    Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
    Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The survival impact of postoperative infection in patients with glioblastoma multiforme.
    Bohman LE; Gallardo J; Hankinson TC; Waziri AE; Mandigo CE; McKhann GM; Sisti MB; Canoll P; Bruce JN
    Neurosurgery; 2009 May; 64(5):828-34; discussion 834-5. PubMed ID: 19404146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond grade: molecular pathology of malignant gliomas.
    Sulman EP; Guerrero M; Aldape K
    Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem gliomas--retrospective analysis of 86 patients.
    Ueoka DI; Nogueira J; Campos JC; Maranhão Filho P; Ferman S; Lima MA
    J Neurol Sci; 2009 Jun; 281(1-2):20-3. PubMed ID: 19345380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
    Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
    J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive markers in glioma and other neuroepithelial tumors.
    Rivera AL; Pelloski CE; Sulman E; Aldape K
    Curr Probl Cancer; 2008; 32(3):97-123. PubMed ID: 18501774
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 expression in malignant melanoma: a novel prognostic marker?
    Becker MR; Siegelin MD; Rompel R; Enk AH; Gaiser T
    Melanoma Res; 2009 Feb; 19(1):8-16. PubMed ID: 19430402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 expression in gastric cancer indicates a poor prognosis.
    Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
    J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
    Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I
    Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG; Aiad HA; Sultan SM
    APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.